CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Smith Hunter C Chief Financial Officer | Option exercise | +3,000 | $17.87 | $54K | 119,611 |
| 2026-05-18 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −3,000 | 79,000 | ||
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,687 | $56.69 | $96K | 1,888 |
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,349 | $49.23 | $66K | 3,237 |
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,406 | $17.97 | $25K | 4,643 |
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Sale | −4,643 | $92.21 | $428K | 0 |
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise · Stock Options (Right to Buy) | −1,687 | 3,713 | ||
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise · Stock Options (Right to Buy) | −1,349 | 2,701 | ||
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Option exercise · Stock Options (Right to Buy) | −1,406 | 2,325 | ||
| 2026-04-01 | Mazabraud Yann EVP, Head of International | Option exercise | +12,875 | 66,030 | ||
| 2026-04-01 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −10,375 | 10,375 | ||
| 2026-04-01 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −2,500 | 5,000 | ||
| 2026-04-01 | Popovits Kimberly J Director | Grant or award · Restricted Stock Units | +6,808 | 6,808 | ||
| 2026-04-01 | Popovits Kimberly J Director | Grant or award · Stock Options (Right to Buy) | +10,257 | 10,257 | ||
| 2026-03-12 | Mathers Edward T Director | Other acquisition | +4,199 | 14,168 | ||
| 2026-03-04 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,500 | $17.97 | $27K | 5,753 |
| 2026-03-04 | German Christopher Paul Corporate Controller & CAO | Sale | −5,614 | $89.56 | $503K | 160 |
| 2026-03-04 | German Christopher Paul Corporate Controller & CAO | Option exercise · Stock Options (Right to Buy) | −1,500 | 3,731 | ||
| 2026-03-02 | Mathers Edward T Director | Other acquisition | +4,198 | 9,969 | ||
| 2026-03-02 | Mazabraud Yann EVP, Head of International | Grant or award · Stock Options (Right to Buy) | +35,000 | 35,000 |
Page 4 of 19 · 376 trades